Select Committee on Health Minutes of Evidence

Letter from the Chief Executive NICE, to the Chairman of the Committee (NC 62A)


  At the Committee hearing on 30 January, Sir Michael Rawlins indicated that the Institute would be submitting further evidence in response to written submissions from other witnesses and statements made by witnesses at earlier hearings.

  We wrote to you last week, setting out our response to the suggestion, by the deputy Editor of the Drugs and Therapeutics Bulletin, that we had failed to respond to correspondence from the Bulletin about their observations on the Institute's revised guidance on zanamivir.

  Two papers are attached to this letter. The first deals with the criticisms of the Institute's guidance made by the Drugs and Therapeutics Bulletin, the British National Formulary and others. The second responds to factual inaccuracies and misunderstanding of the Institute's processes and methodologies, which the Committee may find helpful.

  Please let me know if you require any further information.

5 February 2002

previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2002
Prepared 8 July 2002